Exercise and quality of life in chronic obstructive pulmonary disease: Effects of treatment

Clinical Pulmonary Medicine

Volumn 12, Issue 4 SUPPL., 2005, Pages

  Ferro, Thomas J ^a,c   Schwartz, Douglas B ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STRATTON VA MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic obstructive pulmonary disease; Dyspnea; Exercise; Mortality; Quality of life

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; FORMOTEROL; IPRATROPIUM BROMIDE; LONG ACTING DRUG; SALBUTAMOL; SALMETEROL; SHORT ACTING DRUG; TIOTROPIUM BROMIDE;

AIRFLOW; AIRWAY RESISTANCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISABILITY; DRUG EFFECT; DYSPNEA; EXERCISE; HUMAN; LUNG FUNCTION TEST; LUNG VOLUME; MORTALITY; QUALITY OF LIFE; REVIEW;

EID: 23344446831     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000170510.18825.47     Document Type: Review

References (7)

1. 1a. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;133:14-20.
2. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434-1440.
3. Pinto-Plata VM, Cote C, Cabral H, et al. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004;23:28-33.
4. Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2689-2697.
5. O'Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23:832-840.
6. O'Donnell DE, Voduc N, Fitzpatrick M, et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J. 2004;24:86-94.
7. Vincken W, van Noord JA, Greefhorst AP, et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J. 2002;19:209-216.